Alkermes (ALKS) EBT Margin Growth (1y) (2011 - 2026)
Alkermes (ALKS) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -2,408.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,408.00 |
| Dec 31, 2025 | -2,381.00 |
| Sep 30, 2025 | -359.00 |
| Jun 30, 2025 | -241.00 |
| Mar 31, 2025 | -507.00 |
| Dec 31, 2024 | 2,406.00 |
| Sep 30, 2024 | 481.00 |
| Jun 30, 2024 | -1,640.00 |
| Mar 31, 2024 | 1,733.00 |
| Dec 31, 2023 | -2,213.00 |
| Sep 30, 2023 | 212,959.00 |
| Jun 30, 2023 | 108,471.00 |
| Mar 31, 2023 | 1,221.00 |
| Dec 31, 2022 | -164.00 |
| Sep 30, 2022 | -209,623.00 |
| Jun 30, 2022 | -104,092.00 |
| Mar 31, 2022 | -874.00 |
| Dec 31, 2021 | 5,410.00 |
| Sep 30, 2021 | -985.00 |
| Jun 30, 2021 | 1,227.00 |